Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity.
暂无分享,去创建一个
D. Marin | E. Shpall | B. Andersson | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | A. Alousi | R. Champlin | K. Rezvani | S. Abraham | P. Anderlini | R. Mehta | G. Rondón | C. Hosing | P. Kebriaei | I. Khouri | B. Oran | S. Ciurea | Julianne J Chen | A. Varma | S. Srour | N. Saini | Medhavi Honhar | M. Rashid | Saira S. Ahmed | G. Rondon
[1] MC Ruiz de Elvira. European Group for Blood and Marrow Transplantation , 2020, Definitions.
[2] D. Sacchi,et al. Pathology of idiopathic non-cirrhotic portal hypertension , 2018, Virchows Archiv.
[3] A. Deol,et al. Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation , 2016, American journal of hematology.
[4] M. Ramadwar,et al. Ascites as a Manifestation of GVHD: a Rare Phenomenon , 2016, Indian Journal of Hematology and Blood Transfusion.
[5] M. Abecassis,et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation , 2016, Bone Marrow Transplantation.
[6] Y. Muragaki,et al. Refractory Ascites with Liver Fibrosis Developed in Late Phase Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Patients , 2016, Hematology reports.
[7] E. Carreras. How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation , 2015, British journal of haematology.
[8] A. Berzigotti,et al. Idiopathic portal hypertension: Natural history and long‐term outcome , 2014, Hepatology.
[9] S. Sarin,et al. Non-cirrhotic portal hypertension - diagnosis and management. , 2014, Journal of hepatology.
[10] F. W. Hoffbauer. Liver disease , 2005, The American Journal of Digestive Diseases.
[11] S. Heitner,et al. Chronic GvHD-associated serositis and pericarditis , 2013, Bone Marrow Transplantation.
[12] W. Hiddemann,et al. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. , 2012, The Lancet. Oncology.
[13] C. Tzeng,et al. Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation—association with chronic GVHD in late-onset adult patients , 2012, Annals of Hematology.
[14] P. O’Donnell,et al. Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant , 2012, Leukemia & lymphoma.
[15] M. Díaz-Beyá,et al. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[16] D. Valla,et al. Idiopathic noncirrhotic portal hypertension , 2011, Hepatology.
[17] G. McDonald. Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On , 2010, Hepatology.
[18] Allen R. Chen,et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] Mohannad Abu-Hilal,et al. Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases. , 2009, World journal of gastroenterology.
[20] Y. Chawla,et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 , 2009, Hepatology International.
[21] M. Terol,et al. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] Y. Bayraktar,et al. Hepatic venous outflow obstruction: three similar syndromes. , 2007, World journal of gastroenterology.
[23] V. Arroyo,et al. Refractory Ascites , 2005, Digestive Diseases.
[24] Vincenzo Savarino,et al. Liver enzyme alteration: a guide for clinicians , 2005, Canadian Medical Association Journal.
[25] D. Blaise,et al. Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL , 2003, Bone Marrow Transplantation.
[26] A. Fauser,et al. Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience , 2002, Bone Marrow Transplantation.
[27] D. Valla,et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients , 2002, Gut.
[28] D. Kapoor,et al. Non‐cirrhotic portal fibrosis: Current concepts and management , 2002, Journal of gastroenterology and hepatology.
[29] Jung Lim Lee,et al. Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[30] R. Sackstein,et al. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation , 1999, Bone Marrow Transplantation.
[31] K. Sullivan,et al. Cirrhosis of the liver in long-term marrow transplant survivors. , 1999, Blood.
[32] A. Gratwohl,et al. Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation , 1998 .
[33] J. Kersey,et al. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. , 1996, Bone marrow transplantation.
[34] S. Bearman,et al. The syndrome of hepatic veno-occlusive disease after marrow transplantation. , 1995, Blood.
[35] G. McDonald,et al. Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients , 1993, Annals of Internal Medicine.
[36] M. Dauzat,et al. Portal hypertension in lymphoproliferative and myeloproliferative disorders: Hemodynamic and histological correlations , 1993, Hepatology.
[37] J. Thompson,et al. Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide. , 1992, Blood.
[38] L. Grochow,et al. VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.
[39] M. Farthing,et al. Liver disease after bone marrow transplantation. , 1982, Gut.
[40] M. Washington,et al. The Spectrum of Histologic Findings in Hepatic Outflow Obstruction. , 2017, Archives of pathology & laboratory medicine.
[41] Y. Chawla,et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) , 2009, Hepatology international.
[42] R. Storb,et al. Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. , 2004, Blood.
[43] Pankaj Sharma,et al. Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors , 1984, Hepatology.